Target intelligence / Profile preview

Metronidazole

Molecular classification
Small molecule drug, Nitroimidazole antibiotic, Antiprotozoal agent
01

Overview

Metronidazole is a nitroimidazole antibiotic and antiprotozoal drug used to treat anaerobic bacterial and protozoal infections. It is a prodrug that becomes active only inside susceptible, mainly anaerobic, microorganisms and protozoa, where it is reduced to nitroso free radicals that bind DNA, causing strand breaks and inhibiting nucleic acid synthesis. It is widely used for conditions such as trichomoniasis, giardiasis, amebiasis, bacterial vaginosis, intra-abdominal infections, and for surgical prophylaxis. Metronidazole is NOT a molecular target but a therapeutic agent, and should not be confused with molecular targets such as receptors or enzymes.

Other names
FlagylMetronidazolMétronidazoleMetronidazolumProtostatAnagiardilGineflavirSatricVarious generic brand names
02

Mechanism of action

Reduction within anaerobic microorganisms generates nitroso free radicals. These free radicals induce DNA damage and strand breaks, inhibiting nucleic acid synthesis and leading to cell death.

03

Biological functions

Antibacterial activity (against anaerobic bacteria)Antiprotozoal activityDNA damage in pathogens
04

Disease associations

Infection (anaerobic bacterial infections, protozoal infections)Other (some activity against microaerophilic organisms)
05

Safety considerations

Neurological effects (headache, peripheral neuropathy, seizures)GI disturbances (nausea, metallic taste, loss of appetite)Allergic reactionsAccumulation risk in severe renal disease
06

Interacting drugs

Tinidazole (related agent, same class)

1 more in the full profile.

Beyond the preview

Go deeper on Metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metronidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call